minutos tratamientos de más de siete días.
CEMP campo electromagnético pulsado
Edición | Fibromialgia.nom.es 17-12-2007
Fuente | Pain Research & Management
Concluyendo en; CEMP "puede" ser una novedosa, segura y eficaz herramienta terapéutica para el uso en por lo menos algunos subgrupos de pacientes con enfermedades crónicas, con dolor crónico nomaligno .
A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain
AW Thomas, K Graham, FS Prato, J McKay, P Morley Forster, DE Moulin, S Chari
Exposure to a specific pulsed electromagnetic field (PEMF) has been shown to produce analgesic (antinociceptive) effects in many organisms. In a randomized, double-blind, sham-controlled clinical trial, patients with either chronic generalized pain from fibromyalgia (FM) or chronic localized musculoskeletal or inflammatory pain were exposed to a PEMF (400 µT) through a portable device fitted to their head during twice-daily 40 min treatments over seven days. The effect of this PEMF on pain reduction was recorded using a visual analogue scale. A differential effect of PEMF over sham treatment was noticed in patients with FM, which approached statistical significance (P=0.06) despite low numbers (n=17); this effect was not evident in those without FM (P=0.93; n=15). PEMF may be a novel, safe and effective therapeutic tool for use in at least certain subsets of patients with chronic, nonmalignant pain. Clearly, however, a larger randomized, double-blind clinical trial with just FM patients is warranted.